logo
logo

Abalos Therapeutics Appoints Gerben Moolhuizen As Chief Executive Officer

Oct 09, 2024•about 1 year ago

Position

Chief Executive Officer

Company

Abalos

Gerben Moolhuizen
DüsseldorfBiotechnologyScience And EngineeringHealth Care

Description

Abalos Therapeutics announced the appointment of Gerben Moolhuizen, MBA, as Chief Executive Officer

Company Information

Company

Abalos

Location

Düsseldorf, North Rhine-Westphalia, Germany

About

Abalos Therapeutics has harnessed the unique immune stimulation of the arenavirus to develop a novel anti-cancer approach that provides the full breadth of the immune system’s power specifically against cancer cells. Through viral replication within cancer cells, Abalos’ arenavirus-based drug candidates are designed to awake precise innate and adaptive immune responses and activate all relevant immune cell types against primary tumors and metastases. Led by experienced biotech entrepreneurs and immunology pioneers, Abalos’ goal is to achieve a quantum leap in immuno-oncology.

Related People

Sign in to view contact details

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months